|
|
|
| |
|
|
| |
The latest oncology news from News Medical |
|
|
|
 | | |  Cancer vaccines enter a new era of personalized immunotherapy A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, and effective immunotherapies, particularly when combined with other cancer treatments. | | | | |  FDA warns consumers about fake cancer cures sold online Beware of products claiming to cure cancer on websites or social media platforms, such as Facebook and Instagram. According to Nicole Kornspan, M.P.H., a consumer safety officer at the U.S. Food and Drug Administration (FDA), they're rampant these days. | | | | |  Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a substantial rise in medication treatments, such as chemotherapy, immunotherapy, and hormone therapy, used before surgery to treat many cancers, often allowing less invasive surgery and helping clinicians assess how a patient's cancer responds to medication to guide the most effective treatment options. | | | | |  Metabolic reprogramming drives prostate cancer progression and treatment resistance Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy (ADT), the disease often progresses to castration-resistant prostate cancer (CRPC). | |
|
|
|  | | | | |  Customizable protein platforms offer new hope for cancer treatment Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at the University of Massachusetts Amherst, could have applications beyond cancer to a wide range of immunological diseases, members of the interdisciplinary research team say. | |  | | | | |  Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and the 5-year survival for advanced/metastatic disease is | | | | | | |  Study identifies a powerful strategy to overcome drug resistance in breast cancer A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Communications, identifies a powerful strategy to overcome drug resistance in breast cancer by simultaneously targeting two key cell-cycle regulators, CDK2 and CDK4/6. | | | | | | |  Atypical mutation offers clues to personalized pancreatic cancer treatment A new study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene mutation behaves differently from other variants. | |
|
|
| | | |  The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. | | | | |  When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows. | | | | |  Researchers at FIU are advancing a personalized approach to cancer treatment that is showing increasingly promising results for patients with hard-to-treat disease, supported by new philanthropic investment that is helping expand the science behind the work. | | | | |  Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be. | | | | |  Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole chromosomes, changes that help tumors grow, adapt and resist treatment. | | | | |  We knew we had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue. | | | | | Chemotherapy commonly damages the intestinal lining, a well-known side effect. But this injury does not remain confined to the gut. | | | | | A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic uveal melanoma, a rare and deadly eye cancer. | |
|
|
|
|
|
|
|
